5α-reductase type 1 modulates insulin sensitivity in men. - Wikidata - wikimedia - TriplyDB

5α-reductase type 1 modulates insulin sensitivity in men.

5α-reductase type 1 modulates insulin sensitivity in men.

http://www.wikidata.org/entity/Q34396472

about

[Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data].Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry Relative adrenal insufficiency in mice deficient in 5α-reductase 1 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes.Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy.Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men Metabolic dysfunction in female mice with disruption of 5α-reductase 1 Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?Changes in periprostatic adipose tissue induced by 5α-reductase inhibitors.Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women.Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats.

P2860

Q31149371-AA8481EF-C43B-43C8-96D0-3739F3385F16 Q33463058-C335A642-7165-4597-B690-C9252EE96112 Q33922259-E22D33BF-A114-4FC5-900D-78CA4D74A5B6 Q35878846-58F3ABC0-86C6-46F4-9604-9330F8187C12 Q36109241-32F25281-B1DE-43D0-B69B-AD49523846C6 Q36431676-826BDE0E-0B06-47F1-B638-321BCCFA3A3C Q36911503-E0AC013C-F784-41D5-AF65-786CBDCE62A4 Q37428499-016746CA-5333-4B12-8D4B-049FC95198B0 Q38571198-1663EB98-E8FF-4A83-B401-5F44C3721F54 Q38906372-0CA026DB-69BB-4AC7-A271-A82C130EBA46 Q41637060-08418481-FDE2-4AB9-A6F9-22FEE2E70765 Q41640666-6192D546-86EB-46DE-A7D0-1D78B0C988F2 Q47428562-48E3D943-4E3E-412D-B635-ABA732301DED Q49971559-C20F8407-CA6B-470A-8869-22A0394D4C7B Q55432879-E262C86B-928D-4975-A12B-D06DB46323E9

P2860

5α-reductase type 1 modulates insulin sensitivity in men.

http://www.wikidata.org/entity/Q34396472

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

5α-reductase type 1 modulates insulin sensitivity in men.

@ast

5α-reductase type 1 modulates insulin sensitivity in men.

@en

5α-reductase type 1 modulates insulin sensitivity in men.

@nl

type

label

5α-reductase type 1 modulates insulin sensitivity in men.

@ast

5α-reductase type 1 modulates insulin sensitivity in men.

@en

5α-reductase type 1 modulates insulin sensitivity in men.

@nl

prefLabel

5α-reductase type 1 modulates insulin sensitivity in men.

@ast

5α-reductase type 1 modulates insulin sensitivity in men.

@en

5α-reductase type 1 modulates insulin sensitivity in men.

@nl

P1433

Q34396472-DACF2A3F-C2B2-4153-9DA8-632925406111

P1476

Q34396472-6B0A5531-92EA-40ED-8B76-64DB7EEA777E

P2093

Q34396472-1622377A-0AEA-41A4-B326-6BE090C1FEC0

Q34396472-27EE59CF-CEB5-4B78-9FCA-3304E4FD869D

Q34396472-43CF2AB0-86A3-4788-AD02-7DC46383ED00

Q34396472-8EB75F1E-4598-41F6-9D0E-09DBFA45206B

Q34396472-C0CD0FF0-A411-42AC-A33F-74D5A7EEAF6B

Q34396472-C81F27A0-07A9-4DA1-BDDF-6AFD7A67EE78

Q34396472-C833BF4E-7C01-4317-B01E-A9F777F75EF0

Q34396472-D65C39D8-AB81-4453-99E1-6E8B0D545DFA

P2860

Q34396472-0C50A699-8476-4F1C-AE46-36EA3AD8DD93

Q34396472-209F75D8-F138-4F7C-9ACF-9556969BDB3E

Q34396472-20B754E5-E138-49DB-AD60-32D2F6933671

Q34396472-22DA9C90-33C0-40A6-A883-5B1E2888DE04

Q34396472-31CCE16E-D8EE-4B2D-A0A4-36F5FADE067D

Q34396472-3511F8F7-4E7C-463E-A444-F18A33B7292B

Q34396472-36BAD5D8-A82A-455D-9827-FE7B939A26CD

Q34396472-43F79884-B26F-4004-BB09-3C1E7AA87674

Q34396472-45BAB992-A6A7-48B3-BAD7-1AA9FF16FC9C

Q34396472-482E9EB8-4386-4D99-AFD1-983ED96AC8A8

P304

Q34396472-9CDBF45A-D263-4FF4-967E-235CE86A6415

P31

Q34396472-E730C078-E4F6-47DC-A4E9-DAE7F40EA0ED

P356

Q34396472-2960904D-42E0-45B1-AF8C-BF65EFD25337

P407

Q34396472-18519A1D-BD20-47C8-BC5B-7B29067BE1D8

P433

Q34396472-6181A940-8F82-4D92-A7B9-35F2B026F28C

P478

Q34396472-FC759AA6-A04C-4633-98D4-66A29EC5BDD7

P50

Q34396472-27535942-4FDA-45AC-A902-27E7AABE2F18

Q34396472-ADE70678-929C-4A56-A985-EA927B48AB0E

P577

Q34396472-60047445-43A0-4B00-85E7-E5B4F20B10AB

P5875

Q34396472-9DCBCFB1-04F0-4816-BC9B-AAEDCEB8CF5A

P698

Q34396472-7B825BBA-E364-43E2-91E4-A28233DA0DC2

P921

Q34396472-B1A3C5FD-9830-4808-8F07-962C6CB74AFB

P932

Q34396472-B38A34B8-92B7-4E18-A81E-86709CE04D67

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

5α-reductase type 1 modulates insulin sensitivity in men.

@en

P2093

Brian R Walker

http://www.w3.org/2001/XMLSchema#string

David P Macfarlane

http://www.w3.org/2001/XMLSchema#string

Dawn E W Livingstone

http://www.w3.org/2001/XMLSchema#string

Fiona C Minns

http://www.w3.org/2001/XMLSchema#string

Ian Marshall

http://www.w3.org/2001/XMLSchema#string

Katherine A Hughes

http://www.w3.org/2001/XMLSchema#string

Laurence H Stewart

http://www.w3.org/2001/XMLSchema#string

Rita Upreti

http://www.w3.org/2001/XMLSchema#string

P2860

Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

Java-based graphical user interface for the MRUI quantitation package.

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.

5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

Discovery and clinical development of dutasteride, a potent dual 5alpha-reductase inhibitor.

P304

E1397-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2014-1395

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262303517

http://www.w3.org/2001/XMLSchema#string

P698

24823464

http://www.w3.org/2001/XMLSchema#string

P921

P932

4207930

http://www.w3.org/2001/XMLSchema#string